[1]郑凯,于秀淳,徐明,等.脂质体多柔比星单药治疗老年软组织肉瘤的安全性和有效性研究[J].中华老年骨科与康复电子杂志,2023,(01):11-17.[doi:10.3877/cma.j.issn.2096-0263.2023.01.003]
 Zheng Kai,Yu Xiuchun,Xu Ming,et al.Safety and efficacy of liposome doxorubicin in the treatment of soft tissue sarcoma in the elderly[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2023,(01):11-17.[doi:10.3877/cma.j.issn.2096-0263.2023.01.003]
点击复制

脂质体多柔比星单药治疗老年软组织肉瘤的安全性和有效性研究()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2023年01期
页码:
11-17
栏目:
骨肿瘤
出版日期:
2023-02-05

文章信息/Info

Title:
Safety and efficacy of liposome doxorubicin in the treatment of soft tissue sarcoma in the elderly
作者:
郑凯于秀淳徐明王景明陈倩
250031 中国人民解放军联勤保障部队第九六〇医院骨科
Author(s):
Zheng Kai Yu Xiuchun Xu Ming Wang Jingming Chen Qian.
Department of Orthopaedics, The 960th Hospital of PLA joint logistics support force, Jinan 250031, China
关键词:
软组织肉瘤 老年人 脂质体多柔比星 单药化疗 安全性
Keywords:
Soft tissue sarcoma Aged Liposome doxorubicin Single drug chemotherapy Safety
DOI:
10.3877/cma.j.issn.2096-0263.2023.01.003
文献标志码:
A
摘要:
目的 探讨老年软组织肉瘤脂质体多柔比星单药化疗的安全性和有效性。方法 回顾性分析解放军第九六〇医院2017年1月至2021年1月间所有接受术后辅助化疗的老年软组织肉瘤患者临床资料,按性别、年龄、肿瘤类型、发病部位、保肢情况、辅助化疗方案、化疗不良反应、无疾病生存时间、总生存时间分别进行统计,将所有患者分成脂质体多柔比星化疗组和多柔比星-异环磷酰胺联合化疗组,统计分析两组间患者化疗的安全性和临床有效性。结果 23例患者中有20例(87.0%)老年软组织肉瘤患者纳入本研究,其中男13例(65.0%),女7例(35.0%),发病年龄为60~72岁,平均年龄66.0岁,所有患者病理类型均为高度恶性,未分化多形性肉瘤是最常见的病理类型。脂质体多柔比星单药化疗组7例患者,多柔比星--异环磷酰胺联合化疗组13例患者,对恶心、呕吐、白细胞降低等10项最常见的化疗不良反应进行了统计,参考美国国立癌症研究所不良事件通用术语标准(NCI CTCAE)4.0.3版标准,单药化疗组1~2级不良反应16人次,无3~5级不良反应发生,联合化疗组1~2级不良反应60人次,3级7人次,4级4人次,无5级不良反应发生。组间统计分析显示联合化疗组比单药化疗组需治疗的化疗并发症多,差异存在统计学意义(c2=8.811,P=0.003),化疗后白细胞最小值联合化疗组更低,差异存在统计学意义(F=6.605,P=0.019)。中位无疾病生存时间单药化疗组为12个月,联合化疗组为17个月,单药化疗组随访时间内未出现中位总生存时间,联合化疗组中位总生存时间为35个月,组间差异均无统计学意义。结论 老年软组织肉瘤脂质体多柔比星单药化疗具有更好的安全性,与联合化疗具有相似的临床疗效。
Abstract:
Objective To investigate the safety and efficacy of liposomal doxorubicin monotherapy in elderly soft tissue sarcoma. Methods From January 2017 to January 2021, the clinical data of all elderly patients with soft tissue sarcoma who received surgical treatment and adjuvant chemotherapy in PLA 960th Hospital were retrospectively analyzed. The patients’ gender, age, tumor type, site of disease, limb salvage, adjuvant chemotherapy regimen, adverse reaction of chemotherapy, disease-free survival time, and overall survival time were analyzed. All patients were divided into liposome doxorubicin chemotherapy group and doxorubicin and ifosfamide combined chemotherapy group. The safety and clinical effectiveness of chemotherapy between the two groups were statistically analyzed. Results Among the 23 patients, 20 (87.0%) elderly patients with soft tissue sarcoma were included in this study, including 13 males (65.0%) and 7 females (35.0%). The age of onset was 60-72 years old, with an average age of 66.0 years. The pathological types of all patients were highly malignant, and undifferentiated pleomorphic sarcoma was the most common pathological type. There were 7 patients in liposomal doxorubicin single drug chemotherapy group and 13 patients in doxorubicin ifosfamide combined chemotherapy group. The 10 most common adverse reactions of chemotherapy such as nausea, vomiting and leucopenia were counted. Referring to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 4.0.3 standard, there were 16 times of grade 1-2 adverse reactions and no grade 3-5 adverse reactions in single drug chemotherapy group. There were 60 times of grade 1-2 adverse reactions, 7 times of grade 3 adverse reactions and 4 times of grade 4 adverse reactions, and no grade 5 adverse reactions in combined chemotherapy group. Statistical analysis between groups showed that the combined chemotherapy group had more chemotherapy complications than the single drug chemotherapy group, and the difference was statistically significant (c2=8.811, P=0.003), the minimum value of leukocyte after chemotherapy was lower in the combined chemotherapy group, and the difference was statistically significant (F=6.605, P=0.019). The median PFS in the monotherapy group was 12 months. The median PFS in the combined chemotherapy group was 17 months, the median OS in the single drug chemotherapy group did not appear during the follow-up time, and the median OS in the combined chemotherapy group was 35 months. There was no difference between the groups. Conclusion Liposomal doxorubicin monotherapy has better safety and similar clinical efficacy to combined chemotherapy in elderly soft tissue sarcoma.

相似文献/References:

[1]沈鹏程 朱立帆 蒋富贵 鞠文 徐能 李晓林.锁定钢板结合重建肱骨内侧柱治疗老年不稳定型肱骨近端骨折的疗效分析[J].中华老年骨科与康复电子杂志,2015,(02):7.[doi:10.3877/cma.j.issn.2096-0263.2015.02.002]
 Shen Pengcheng,Zhu Lifan,Jiang Fugui,et al.Clinical research of locking plate combined with medial column mechanical support for unstable fractures of the proximal humerus in elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2015,(01):7.[doi:10.3877/cma.j.issn.2096-0263.2015.02.002]
[2]刘文宣 张宇宸 刘文聪 高霞 李涛 张晓琳.CTR 基因多态性与老年男性骨质疏松的相关性研究[J].中华老年骨科与康复电子杂志,2015,(02):19.[doi:10.3877/cma.j.issn.2096-0263.2015.02.004]
 Liu Wenxuan,Zhang Yuchen,Liu Wencong,et al.Association between calcitonin receptor gene polymorphism and osteoporosis in elderly men[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2015,(01):19.[doi:10.3877/cma.j.issn.2096-0263.2015.02.004]
[3]董仁卫 郭琪 王家仲 王连成.老年人群肌力水平与心血管疾病 三大危险因素的相关性研究[J].中华老年骨科与康复电子杂志,2015,(02):29.[doi:10.3877/cma.j.issn.2096-0263.2015.02.006]
 Dong Renwei,Guo Qi,Wang Jiazhong,et al.The association between muscle strength level and three major risk factors of cardiovascular disease in elderly population[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2015,(01):29.[doi:10.3877/cma.j.issn.2096-0263.2015.02.006]
[4]李森磊,孙立,杨先腾,等.老年髋关节置换术后认知功能障碍的危险因素分析[J].中华老年骨科与康复电子杂志,2016,(02):71.[doi:10.3877/cma.j.issn.2096-0263.2016.02.002]
 Li Senlei,Sun Li,Yang Xianteng,et al.Risk factors analysis for postoperative cognitive dysfunction in  elderly patients undergoing hip arthroplasty[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):71.[doi:10.3877/cma.j.issn.2096-0263.2016.02.002]
[5]钟俊青,王连成.快速外科通道理念对老年股骨转子间骨折围手术期康复指导的前瞻性研究[J].中华老年骨科与康复电子杂志,2016,(02):87.[doi:10.3877/cma.j.issn.2096-0263.2016.02.005]
 Zhong Junqing,Wang Liancheng..Prospective study of the effect of fast track surery on peri-operative rehabilitation of elderly intertrochanteric fracture[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):87.[doi:10.3877/cma.j.issn.2096-0263.2016.02.005]
[6]赵德伟,马志杰,杨磊,等.多孔钽金属涂层髋关节假体置换治疗老年股骨颈骨折的临床疗效观察[J].中华老年骨科与康复电子杂志,2016,(02):92.[doi:10.3877/cma.j.issn.2096-0263.2016.02.006]
 Zhao Dewei,Ma Zhijie,Yang Lei,et al.Clinical investigation of hip implants by using porous tantalum coating in the treatment of elderly femoral neck fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):92.[doi:10.3877/cma.j.issn.2096-0263.2016.02.006]
[7]吴啸波,裴宝瑞.老年髋部骨折围手术期相关问题的研究进展[J].中华老年骨科与康复电子杂志,2016,(02):114.[doi:10.3877/cma.j.issn.2096-0263.2016.02.010]
 Wu Xiaobo,Pei Baorui..Perioperative related problems of surgery in elderly patients with hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):114.[doi:10.3877/cma.j.issn.2096-0263.2016.02.010]
[8]宋会平,张柳.阿仑膦酸钠治疗老年女性严重骨质疏松症患者的疗效分析[J].中华老年骨科与康复电子杂志,2016,(03):141.[doi:10.3877/cma.j.issn.2096-0263.2016.03.003]
 Song Huiping,Zhang Liu.Effcacy analysis of alendronate in the treatment of severe osteoporosis in senile women[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):141.[doi:10.3877/cma.j.issn.2096-0263.2016.03.003]
[9]柴仪,田伟明,温志刚.经皮椎体后凸成形术治疗高龄骨质疏松性椎体压缩骨折的疗效分析[J].中华老年骨科与康复电子杂志,2016,(03):150.[doi:10.3877/cma.j.issn.2096-0263.2016.03.005]
 Chai Yi,Tian Weiming,Wen Zhigang.Curative effective analysis of percutaneous kyphoplasty for osteoporotic vertebral compression fracture in senile patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):150.[doi:10.3877/cma.j.issn.2096-0263.2016.03.005]
[10]陈旭光,张天燕,单新1,等.围术期抑郁对老年骨科手术患者单核细胞组织因子表达及血小板功能的影响[J].中华老年骨科与康复电子杂志,2016,(03):155.[doi:10.3877//cma.j.issn2096-2063.2016.03.006]
 Chen Xuguang,Zhang Tianyan,Shan Xin,et al.Effect of depressive disorder on tissue factor expression of monocytes and platelet function in elderly patients undergoing orthopaedic surgery[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):155.[doi:10.3877//cma.j.issn2096-2063.2016.03.006]
[11]郑凯,于秀淳,徐明,等.老年软组织肉瘤临床特征及治疗方案的研究[J].中华老年骨科与康复电子杂志,2021,(06):352.[doi:10.3877/cma.j.issn.2096-0263.2021.06.006]
 Zheng Kai,Yu Xiuchun,Xu Ming,et al.Clinical features and treatment options of soft tissue sarcoma in the elderly[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2021,(01):352.[doi:10.3877/cma.j.issn.2096-0263.2021.06.006]

备注/Memo

备注/Memo:
基金项目:山东省医药卫生科技发展计划项目课题(202104071065)
更新日期/Last Update: 2023-03-30